European Patent Office

T 0844/18 (CRISPR-Cas/BROAD INSTITUTE) du 16.01.2020

Identifiant européen de la jurisprudence
ECLI:EP:BA:2020:T084418.20200116
Date de la décision
16 janvier 2020
Numéro de l'affaire
T 0844/18
Requête en révision de
-
Numéro de la demande
13818570.7
Classe de la CIB
C12N 15/63
Langue de la procédure
Anglais
Distribution
Non distribuées (D)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
Engineering of systems, methods and optimized guide compositions for sequence manipulation
Nom du demandeur
The Broad Institute, Inc.
Massachusetts Institute of Technology
President and Fellows of Harvard College
Nom de l'opposant
Schlich, George
Grund, Dr., Martin
Regimbeau
CRISPR Therapeutics AG
Storz, Dr. Ulrich
Novozymes A/S
Boxall Intellectual Property Management Limited
Sagittarius Intellectual Property LLP
Adams, Harvey Vaughan John
Chambre
3.3.08
Sommaire
-
Dispositions juridiques pertinentes
Accord Healthcare -v- Research Corporation Technologies [2017] EWHC 2711 (Ch)European Convention on Human Rights Art. 1 of Protocol No. 1European Patent Convention Art 112(1)(a) (2007)European Patent Convention Art 54(3) (2007)European Patent Convention Art 60(3) (2007)European Patent Convention Art 87(1) (2007)European Patent Convention Art 87(2) (2007)European Patent Convention Art 87(3) (2007)European Patent Convention Art 88(1) (2007)European Patent Convention Art 90(3) (2007)European Patent Convention Art 90(5) (2007)European Patent Convention R 52 (2007)European Patent Convention R 53 (2013)KCI Licensing -v- Smith & Nephew [2010] EWHC 1487 (Pat)Notice from the President of the EPO dated 26 January 1996 concerning priority conferring effect of the "US provisional application for a patent"Paris Convention_Art. 4A, 4A(1), 4A(2), 4A(3), 4D, 4D(1), 4D(4), 4F, 4G, 19PCT_Art. 8(1), 8(2)(a), 8(2)(b)Riendeau -v- Zehnder Group International AG, Swiss Federal Patent Court, 21 March 2018The Constitution of the United States Art. VI, clause 2VCLTIO_Art. 31(1), 33(4)
Mots-clés
Priority - main request (no)
Novelty - main request (no)
Exergue
i) The board is empowered to and must assess the validity of a priority right claim as required by Article 87(1) EPC,
ii) the board's interpretation of the expression "any person" in Article 87(1) EPC confirms the long-established "all applicants" or the "same applicants" approach,
iii) the national law does not govern who is "any person" as per Article 87(1) EPC, the Paris Convention determines who "any person" is.

Order

For these reasons it is decided that:

The appeal is dismissed.